Register entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- Sweden
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| APL Strangnas AB | Mariefredsvagen 35, Strangnas, 64541, Sweden (SWE) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3006524831351517771 |
Neighbours
Registered in the same town
1- Pfizer IncStrangnas, SWE
Compare
Comparable companies in Sweden
- Cambrex Karlskoga AB1 site · 13 NDC
- PolyPeptide Laboratories Sweden AB1 site · 9 NDC
- Sever Pharma Solutions AB1 site · 1 NDC
- Eurofins BioPharma Product Testing Sweden AB2 sites · 0 NDC
- Apotek Produktion & Laboratorier AB3 sites · 0 NDC
Enquiry
Common questions
- Is APL Strangnas AB FDA approved?
- APL Strangnas AB holds 1 FDA-registered establishment in Sweden. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are APL Strangnas AB's drugs manufactured?
- The FDA register lists Strangnas. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.